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Introduction: Distal gastrectomy with jejunal interposition (DGJI) has been used in our institution for
selected patients with gastric cancer as a function-preserving gastrectomy. The aim of this retrospective
study was to clarify the feasibility and functional efﬁcacy of DGJI.
Methods: A retrospective analysis was performed in 61 patients who underwent DGJI between 2002 and
2011.
Results: Mean operation time was 393.8 min and blood loss was 463.3 ml. Postoperative early major
complications developed in 2 (3.3%) patients. The most common complication was gastric stasis,
occurring in 7 (11.5%) patients. All patients with complications recovered with conservative treatment,
and no operative mortality occurred. Endoscopy 1 year after operation revealed reﬂux gastritis in 1
patient. Reﬂux esophagitis was not found in any patient. However, anastomotic ulcer was found in 12
(22.2%) patients over the 1-year period after operation. No patient reported symptoms of early and late
dumping syndrome, and 1 (1.9%) patient self-reported diarrhea.
Conclusions: DGJI was a feasible and safe procedure with several advantages in terms of less incidence of
reﬂux gastritis and esophagitis, dumping syndrome and diarrhea. However, this procedure is compli-
cated and time-consuming, and it is necessary to be aware of the potential occurrence of an anastomotic
ulcer at the site of the gastrojejunostomy after DGJI.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Although gastric cancer is one of the most common causes of
cancer death worldwide,1 early gastric cancer has accounted for
nearly 50% of all gastric cancers in Japan.2 Early gastric cancer has
an excellent prognosis after surgical treatment, with 5-year sur-
vival rates of more than 90%. Japanese surgeons have therefore
focused on symptom relief to improve the quality of life of long-
term survivors. This has led to function-preserving surgery to
minimize postgastrectomy syndrome, which includes symptoms
such as postoperative weight loss, diarrhea, early and late dumping
syndrome, and bile reﬂux gastritis and esophagitis.
In our institution, distal gastrectomy with jejunal interposition
(DGJI) has been used as a function-preserving surgery for selected
patients with gastric cancer since January 1994. We also reported
the beneﬁt of this procedure in a small comparative study in 2000.3
Since that report, sentinel lymph node biopsy4 has been added to: þ81 97 556 1778.
omiya).
ciates Ltd. Published by Elsevier Ltthis procedure, and the celiac branch of the vagus nerve has also
been preserved in selected patients from 2002. We retrospectively
analyzed 61 serial patients who underwent DGJI between 2002 and
2011 at our institution to clarify the feasibility, safety, and post-
operative functional result of this procedure.
2. Methods
Between 2002 and 2011, 215 patients with gastric cancer un-
derwent surgery at Arita Gastrointestinal Hospital, Oita, Japan.
During this period, we performed DGJI in 61, Roux-en-Y (RY)
reconstruction in 38, Billroth I in 6, and pylorus-preserving gas-
trectomy (PPG) in 34 patients. As well, total gastrectomy was per-
formed in 32, proximal gastrectomy in 20, and wedge resection in
24 patients. This study enrolled the 61 patients who underwent
DGJI. Our indications for DGJI were as follows: (1) early cancer
located in the lower third of the stomach (contraindication for PPG
and endoscopic submucosal dissection according to the gastric
cancer treatment guideline5); (2) advanced cancer without lymph
node metastasis by preoperative assessment; and (3) without se-
vere general health problems and history of other disease.d. All rights reserved.
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and computed tomography for characterization of the tumors. In-
formation was collected from the medical chart and anesthesia
records and included patient age, sex, body mass index, American
Society of Anesthesiologists physical status, rates of sentinel lymph
node biopsy and preservation of the celiac branch of the vagus,
duration of operation, estimated blood loss, blood transfusion,
pathological ﬁndings, postoperative early and late complications,
and recurrence and survival rates. The pathological ﬁndings were
assessed in accordance with criteria outlined by the Japanese
Gastric Cancer Society.6
2.1. Operative technique
Sentinel lymph node biopsy was performed as reported previ-
ously.4 DGJI was performed according to our previous report.3 In
brief, a 10e12 cm section of jejunum, whichwas prepared at a point
20e30 cm distal from the ligament of Treitz, was brought through
the transversemesocolon, andwas anastomosed in an isoperistaltic
orientation to the greater curvature of the stomach and duodenum
with a single layer of interrupted sutures (Fig. 1). Both gastrojejunal
and jejunoduodenal anastomoses were performed end to end.
2.2. Deﬁnitions of postoperative early complications
Postoperative minor complications were deﬁned as either any
abdominal ﬁnding during the postoperative course not requiring
medication or a systemic complication requiring pharmacologic
treatment. Major postoperative complications were deﬁned as any
complications requiring surgical or radiological intervention.
2.3. Assessment of postoperative late complications
Patients underwent follow-up examinations every 3 months for
2 years after surgery and every 6 months thereafter. Seven patients
were excluded from the assessment of postoperative late compli-
cations 1 year after operation because of inadequate postoperative
data. The presence of body weight change, dumping syndrome, and
diarrhea were assessed via self-reporting, and reﬂux gastritis,
esophagitis, and the presence of anastomotic ulceration were
assessed endoscopically 1 year after surgery. Reﬂux gastritis and
esophagitis were assessed endoscopically according to the degree
of epithelial redness and erosion present.Fig. 1. Operative photograph shows distal gastrectomy with jejunal interposition. A
10e12-cm section of the jejunum was brought through the transverse mesocolon and
anastomosed in an isoperistaltic orientation to the greater curvature of the gastric
remnant and duodenum. GR, gastric remnant; IJ, interposed jejunum; D, duodenum;
CB, celiac branch of the vagus.2.4. Statistical analysis
Values are expressed as mean  standard deviation. Survival
rates were calculated by the KaplaneMeier method.
3. Results
There were 44 were men and 17 women with a mean age of
61.5  10.8 (range 32e78) years and mean body mass index of
22.7  2.8 (range 17.3e28.4) kg/m2 (Table 1). All operations were
carried out with curative intent. Sentinel lymph node biopsy was
performed in 47 (77.0%) patients, and the celiac branch of the vagus
nerve was preserved in 58 (95.1%) patients. The duration of oper-
ation was 393.8  89.0 (range 265e580) min, blood loss was
436.3  232.7 (range 94e1281) ml, and 1 (1.6%) patient required
perioperative blood transfusion. The number of harvested nodes
was 31.1  15.8 (range 6e71), and the incidence of nodal involve-
ment was 26.2% overall (16 of 61 patients). According to the path-
ological ﬁndings, 40 patients had stage IA disease, 6 had stage IB, 6
had stage IIA, 6 had stage IIB and 3 had stage IIIA disease (Table 2).
Postoperative oral adjuvant chemotherapy was administered in 16
patients (26.2%). Median follow-up time was 47 (range 3e124)
months. Five patients developed recurrence, and 4 died as a result
of peritoneal metastasis. One patient developed liver metastasis
but was still alive at the time of writing. The overall 5-year survival
rate was 88.1%.
Postoperative early complications developed in 11 (18.0%) pa-
tients. Major complications occurred in 2 patients: anastomotic
leakage in 1 (1.6%) and deep vein thrombus in 1 (1.6%). The patient
with anastomotic leakage was cured by conservative therapy using
radiographic intervention. Gastric stasis, the most frequent
complication, occurred in 7 (11.5%) patients, all of whom had
symptoms requiring fasting and intravenous ﬂuid support. Total
parenteral nutrition was not used in any of these 7 patients with
gastric stasis. All patients with early complications recovered with
conservative treatment, and no operative mortality occurred
(Table 3).
The assessment of postoperative late complications 1 year after
operation is shown in Table 4. The body weight ratio 1 year after
surgery was 94.1  8.0 (range 72e109.5) per cent. Bile reﬂux
gastritis was found in 1 (1.9%) patient, but reﬂux esophagitis was
not found in any of the 54 patients by endoscopy at 1 year after
operation. However, anastomotic ulcer was found in 12 (22.2%)
patients during the 1-year period after operation. No patient re-
ported symptoms of early and late dumping syndrome, and 1 (1.9%)
patient self-reported diarrhea.
4. Discussion
A recent report by The Japanese Society for the Study of
Postoperative Morbidity after Gastrectomy (JSSPMG)7 clariﬁedTable 1
Background of the 61 patients who underwent distal gastrectomy with jejunal
interposition.
Characteristics Values
Age (years)a 61.5  10.8 [32e78]
Sex ratio (M:F)b 44 (72.1):17 (27.9)
Body mass index (kg/m2)a 22.7  2.8 [17.3e28.4]
ASAc physical status
1 44 (72.1)
2 17 (27.9)
a Values are mean  standard deviation [range].
b Values are number (%).
c ASA, American Society of Anesthesiologists.
Table 2
Clinicopathological details of the 61 patients who underwent distal gastrectomy
with jejunal interposition.
Factors Values
Sentinel lymph node biopsy (%)a 47 (77.0)
Preservation of celiac branch of the vagus (%)a 58 (95.1)
Duration of operation (min)b 393.8  89.0 [265e580]
Blood loss (ml)b 436.3  232.7 [94e1281]
Blood transfusion (%)a 1 (1.6)
Number of harvested nodesb 31.1  15.8 [6e75]
Nodal involvement (%)a 16 (26.2)
Stage
IA 40
IB 6
IIA 6
IIB 6
IIIA 6
a Values are number (%).
b Values are mean  standard deviation [range].
Table 4
Postoperative late complications in 54 patients 1 year after distal gastrectomy with
jejunal interposition.
Findings Values
Ratio of body weight change (%)a 94.1 (8.0) [72e109.5]
Endoscopyb
Reﬂux gastritis 1 (1.9)
Reﬂux esophagitis 0 (0)
Anastomotic ulcer 12 (22.2)
Dumping syndromeb 0 (0)
Diarrheab 1 (1.9)
a Value is mean  standard deviation [range].
b Values are number (%).
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Japan. According to their report, the most common methods of
reconstruction after distal gastrectomy were Billroth I in 77%, RY
in 21%, PPG in 1.3%, and Billroth II in 0.7% of patients. Recently,
according to the questionnaire survey reported by the JSSPMG,7
the frequency of RY after distal gastrectomy has been gradually
increasing due to beneﬁts such as the prevention of reﬂux and
the low complication rate. However, RY reconstruction is known
to cause RY stasis, reported in 71% of patients by the responders
to the questionnaire.7 In addition, Ishikawa et al.8 reported that
RY did not prevent esophagitis in their randomized controlled
trial because RY induced RY stasis as a complication. PPG is also a
function-preserving procedure devised by Maki and colleagues9
in 1967. According to previous reports,10,11 PPG offers many
beneﬁts over conventional distal gastrectomy with Billroth I
anastomosis, with a low incidence of postgastrectomy syndrome.
However, a recent study12 reported that symptoms after PPG
were better in those patients in whom the antral cuff was longer
than 1.5 cm, as Maki et al. had noted in their original article
describing PPG.9 Indications for PPG are limited because the
gastric cancer treatment guideline5 states that PPG may be
considered in T1 and N0 patients when the tumor is located in
the middle third of the stomach with its distal edge greater than
4 cm from the pylorus. Therefore, PPG should not be performed
in patients especially when the tumor is located in the lower
third of the stomach.
Jejunal interposition between the gastric remnant and the
duodenum (gastrojejunoduodenostomy) was ﬁrst described by
Henley.13 Several other authors14,15 have also reported the use of
jejunal interposition for prevention of reﬂux gastritis and
esophagitis. We previously demonstrated favorable results of
DGJI3 and concluded that this procedure is an acceptable surgical
modality for selected patients with gastric cancer. Although DGJITable 3
Postoperative early complications in the 61 patients after distal
gastrectomy with jejunal interposition.
Complications Values
Major complications
Anastomotic leakage 1 (1.6)
Deep vein thrombus 1 (1.6)
Minor complications
Gastric stasis 7 (11.5)
Lymphatic leakage 1 (1.6)
Cholecystitis 1 (1.6)
Total 11 (18)
Values are number (%).has several functional advantages compared with the Billroth I
anastomosis, there exist some disadvantages for the use of DGJI
in all patients with gastric cancer in that this surgical procedure
requires three anastomoses compared with one in the Billroth I
anastomosis, resulting in longer operation time and greater
blood loss according to our previous report.3 Therefore, we per-
formed this procedure in 61 selected patients who were without
severe general health problems and history of other disease and
in whom prediction of prognosis was excellent due to meticulous
preoperative assessment.
DGJI is a complicated procedure because it requires three
anastomoses compared with the one required in a Billroth I
reconstruction. The present study showed that postoperative early
complications developed in 18.0% of the patients. However, major
complications requiring surgical or radiological intervention
occurred in only 3.3% of the patients. In addition, the patient with
anastomotic leakage was cured by radiographic intervention. The
most frequent early complication was gastric stasis, occurring in
11.5% of patients, of whom all recovered with temporary fasting
and intravenous ﬂuid support. The rate of gastric stasis was
considered acceptable compared with reported rates of RY stasis
of 71.0% and of gastric stasis of 8.0% in PPG.16 In terms of post-
operative early complications, we therefore considered DGJI to be
a safe procedure.
We demonstrated favorable functional results 1 year after
DGJI: there were low rates of weight loss, dumping syndrome,
diarrhea, and reﬂux gastritis and esophagitis. However, endos-
copy performed during the 1 year after operation revealed that
12 (22.2%) of 54 patients had anastomotic ulcer at the site of the
gastrojejunostomy. The mechanism and cause of anastomotic
ulceration were not well understood because the number of
patients who underwent DGJI in the present study was very
small. Although all patients with anastomotic ulceration were
cured by medication using a histamine 2 receptor antagonist or
proton pump inhibitor, further accumulation of cases and ex-
aminations is necessary to clarify the mechanism and cause of
anastomotic ulcer after DGJI.
We previously reported the beneﬁts of DGJI using retrospective
data in 20 patients who underwent DGJI.3 To our best knowledge,
there have been no reports on the feasibility and efﬁcacy of DGJI
since our previous report. Therefore, the present study might be
helpful in terms of showing the recent surgical outcomes of DGJI by
analyzing 61 patients who underwent DGJI. However, the present
study has some limitations. This was retrospective case series. We
did not examine the superiority or inferiority of DGJI in comparison
with conventional reconstruction (Billroth I and RY) because the
clinical background of the patients was different between these
three procedures (DGJI, Billroth I, and RY). The reasonwhy was that
since 2002, we have performed conventional reconstruction only in
patients with severe general health problems and a history of other
disease and in whom a poor prognosis was predicted by
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ﬁed randomization are needed to conﬁrm the surgical outcomes of
DGJI.
5. Conclusion
Despite some limitations, our study showed that DGJI was
feasible and offered several advantages in terms of less post-
operative weight loss and low rates of reﬂux gastritis and esoph-
agitis, dumping syndrome, and diarrhea compared with other
reconstruction procedures. DGJI can therefore be recommended as
a valid option following distal gastrectomy. However, DGJI should
be indicated only for those patients without severe general health
problems and history of other disease because it is complicated and
time-consuming. Additionally, it is necessary to be aware of the
potential occurrence of an anastomotic ulcer at the site of the
gastrojejunostomy after DGJI.
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